NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company offering non-invasive, rapid testing solutions, today ...
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
The global nasal drug delivery technology market is projected to grow at a CAGR of approximately 7% over the next five years.
Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic ...
Hosted on MSN
How Epinal’s Narcolyzer addresses a growing emergent need for non-invasive, rapid, handheld narcotics testing
Public institutions across the world are reassessing how they identify and respond to narcotic impairment. Courts, transportation agencies, probation departments, and treatment programs are ...
Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational drug-device combination to treat certain patients with non-muscle invasive ...
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results